Breaking News, Collaborations & Alliances

Mindset Pharma Enters CDMO Manufacturing Agreement

Partners with leading CDMO to produce pharmaceutical grade batches of next-generation psilocybin drug candidate, MSP-1014.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mindset Pharma Inc., a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO), for the production of pharmaceutical grade batches of Mindset’s next-generation psilocybin drug candidate, MSP-1014. “Following our co-developmen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters